DK94487D0 - Fremgangsmaade til fremstilling af encainid - Google Patents

Fremgangsmaade til fremstilling af encainid

Info

Publication number
DK94487D0
DK94487D0 DK094487A DK94487A DK94487D0 DK 94487 D0 DK94487 D0 DK 94487D0 DK 094487 A DK094487 A DK 094487A DK 94487 A DK94487 A DK 94487A DK 94487 D0 DK94487 D0 DK 94487D0
Authority
DK
Denmark
Prior art keywords
encainid
manufacturing
manufacturing encainid
Prior art date
Application number
DK094487A
Other languages
English (en)
Other versions
DK94487A (da
Inventor
John L Dillon
Richard H Spector
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DK94487D0 publication Critical patent/DK94487D0/da
Publication of DK94487A publication Critical patent/DK94487A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/02—Preparation by ring-closure or hydrogenation

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK094487A 1986-02-25 1987-02-24 Fremgangsmaade til fremstilling af encainid DK94487A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/833,295 US4675409A (en) 1986-02-25 1986-02-25 Process for the preparation of encainide

Publications (2)

Publication Number Publication Date
DK94487D0 true DK94487D0 (da) 1987-02-24
DK94487A DK94487A (da) 1987-08-26

Family

ID=25264016

Family Applications (1)

Application Number Title Priority Date Filing Date
DK094487A DK94487A (da) 1986-02-25 1987-02-24 Fremgangsmaade til fremstilling af encainid

Country Status (23)

Country Link
US (1) US4675409A (da)
JP (1) JPS62240659A (da)
KR (1) KR900001203B1 (da)
AT (1) AT394716B (da)
AU (1) AU597939B2 (da)
BE (1) BE1000112A5 (da)
CA (1) CA1291483C (da)
CH (1) CH671223A5 (da)
DE (1) DE3705664A1 (da)
DK (1) DK94487A (da)
ES (2) ES2002637A6 (da)
FI (1) FI85853C (da)
FR (1) FR2595353B1 (da)
GB (1) GB2187189B (da)
GR (1) GR870281B (da)
HU (1) HU196960B (da)
IL (1) IL81657A0 (da)
IT (1) IT1203501B (da)
LU (1) LU86785A1 (da)
NL (1) NL8700452A (da)
PT (1) PT84348B (da)
SE (1) SE464301B (da)
ZA (1) ZA871334B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800226A (en) * 1986-02-25 1989-01-24 Bristol-Myers Company Process intermediate for the preparation of encainide
EP1994001A2 (en) * 2005-11-17 2008-11-26 Novartis AG Benzeneszkfibate salts and their use as intermediates for the synthesis of 2-[2-(1-alkyl-2-piperidyl)ethyl] cinnamanilides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931195A (en) * 1971-03-03 1976-01-06 Mead Johnson & Company Substituted piperidines
CA961038A (en) * 1971-03-03 1975-01-14 Bristol-Myers Canada Limited Substituted piperidines
US4000143A (en) * 1971-03-03 1976-12-28 Mead Johnson & Company Substituted piperidines
US4064254A (en) * 1971-03-03 1977-12-20 Mead Johnson & Company Substituted piperidines therapeutic process and compositions
US4394507A (en) * 1981-12-14 1983-07-19 Mead Johnson & Company Process for production of encainide

Also Published As

Publication number Publication date
PT84348A (en) 1987-03-01
GB2187189B (en) 1990-01-10
NL8700452A (nl) 1987-09-16
FI85853C (fi) 1992-06-10
ATA41287A (de) 1991-11-15
FI85853B (fi) 1992-02-28
SE8700776L (sv) 1987-08-26
CH671223A5 (da) 1989-08-15
HUT43563A (en) 1987-11-30
AU597939B2 (en) 1990-06-14
AU6924687A (en) 1987-08-27
PT84348B (pt) 1989-09-14
CA1291483C (en) 1991-10-29
IL81657A0 (en) 1987-09-16
SE464301B (sv) 1991-04-08
JPS62240659A (ja) 1987-10-21
ZA871334B (en) 1987-10-28
KR870007887A (ko) 1987-09-22
US4675409A (en) 1987-06-23
FR2595353A1 (fr) 1987-09-11
ES2002637A6 (es) 1988-09-01
ES2007062A6 (es) 1989-06-01
GB2187189A (en) 1987-09-03
FI870767L (fi) 1987-08-26
FR2595353B1 (fr) 1990-11-30
HU196960B (en) 1989-02-28
SE8700776D0 (sv) 1987-02-24
IT8719475A0 (it) 1987-02-24
AT394716B (de) 1992-06-10
DE3705664C2 (da) 1989-09-28
IT1203501B (it) 1989-02-15
DE3705664A1 (de) 1987-08-27
KR900001203B1 (ko) 1990-02-28
BE1000112A5 (fr) 1988-03-29
GB8703882D0 (en) 1987-03-25
LU86785A1 (fr) 1987-09-15
FI870767A0 (fi) 1987-02-23
DK94487A (da) 1987-08-26
GR870281B (en) 1987-06-30

Similar Documents

Publication Publication Date Title
DK238988D0 (da) Fremgangsmaade til fremstilling af 4-acyloxy-3-hydroxyethyl-azetidinoner
DK100688A (da) Fremgangsmaade til fremstilling af cement
DK366684D0 (da) Fremgangsmaade til fremstilling af cefuroximaxetil
DK223587A (da) Fremgangsmaade til fremstilling af azopigmenter
DK446987A (da) Fremgangsmaade til fremstilling af smoer
DK165250C (da) Fremgangsmaade til fremstilling af 2-amino-6-chlorpurin
DK14589A (da) Fremgangsmaade til fremstilling af 1-alkyl-5-nitroimidazoler
DK223487D0 (da) Fremgangsmaade til fremstilling af azopigmenter
DK531085A (da) Fremgangsmaade til fremstilling af hydroquinonderivater
DK78388A (da) Fremgangsmaade til fremstilling af 4-acetoxy-3-hydroxyethyl-azetidinon
DK65887A (da) Fremgangsmaade til fremstilling af l-sorbose
DK444187A (da) Fremgangsmaade til genvinding af oel
DK121386A (da) Fremgangsmaade til fremstilling af guanidiner
DK33985D0 (da) Fremgangsmaade til fremstilling af acetone
DK117487A (da) Fremgangsmaade til fremstilling af inulase
DK329685A (da) Fremgangsmaade til fremstilling af alfa-l-aspartyl-l-phenylalaninalkylestere
DK94487A (da) Fremgangsmaade til fremstilling af encainid
DK453586D0 (da) Fremgangsmaade til fremstilling af 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamid
DK202983A (da) Fremgangsmaade til fremstilling af l-lysin
DK190187D0 (da) Fremgangsmaade til fremstilling af n-aminophthalimid
DK60287A (da) Fremgangsmaade til fremstilling af 4-acetyl-isoquinolinon-forbindelser
DK551582A (da) Fremgangsmaade til fremstilling af encainid
DK499187A (da) Fremgangsmaade til fremstilling af glycopeptidantibiotika
DK593385D0 (da) Fremgangsmaade til fremstilling af l-carnitin
DK500688D0 (da) Fremgangsmaade til fremstilling af masolin

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment